Cyprus – Antineoplastic and immunomodulating agents – Προσφορά για την προμήθεια Σκευάσματος Teprotumumab για κάλυψη άμεσων αναγκών Φ.Υ.Υ. 76/2026 ΥΥ
Opportunity Score
Confidence: 35%
Complexity: low
3 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Supply of Teprotumumab for immediate needs by the Ministry of Health of Cyprus. Single lot, open procedure, lowest price award. Estimated value €193,534 for 6 months. Submission deadline 18 June 2026, electronic submission in Greek only.
Strengths
Documents available
Open procedure
Low complexity
Risks
Submission deadline in 3 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Electronic submission required
- Submission language: Greek (ELL)
- No variants allowed
Buyer
Lots (1)
Προμήθεια Σκευάσματος Teprotumumab για κάλυψη άμεσων αναγκών
Procurement Details
Publication
03 Jun 2026
Deadline
18 Jun 2026, 10:00
Procedure
open
Contract
supplies
Duration
6 MONTH
Language
ELL
Publication #
384022-2026
Classification
Performance: Cyprus
Documents (2)
Opportunity Score
Confidence: 35%
Complexity: low
3 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation